Reciprocal Relationship Identified Between T2D, Asthma
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 11, 2024 -- There is a reciprocal relationship between asthma and type 2 diabetes (T2D), according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 9 to 13 in Madrid.
Nam Nhat Nguyen, M.D., from Taipei Medical University in Taiwan, and colleagues conducted a systematic review and meta-analysis to examine the interconnection between asthma and T2D and explore potential underlying factors and mechanisms. The meta-analysis included data on 17 million individuals from 14 studies conducted across continents and countries. Participants were mainly aged 50 to 70 years.
The researchers found a reciprocal relationship between asthma and diabetes: Compared with those without asthma, individuals with asthma were 28 percent more likely to develop T2D, and individuals with T2D were 83 percent more likely than those without T2D to develop asthma. There was an association for asthma severity with an increased risk for T2D, but no association was seen for asthma duration with T2D risk.
"Our findings have important implications for clinical practice. Firstly, this relationship emphasizes the need for greater awareness among patients with type 2 diabetes or asthma and their health care providers," Nguyen said in a statement. "Secondly, preventive strategies should be considered to lower the risk of type 2 diabetes in individuals with asthma."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Muscle Ultrasound Can Detect Insulin Resistance
MONDAY, June 30, 2025 -- Muscle ultrasound can detect insulin resistance and lower muscle mass, according to a study published online June 12 in the Journal of Ultrasound...
Disparities Seen in Continuous Glucose Monitor Rx by Language Preference
FRIDAY, June 27, 2025 -- For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language preference, with less access...
ADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2 Diabetes
FRIDAY, June 27, 2025 -- Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated hemoglobin (HbA1c) among...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.